Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription


2 Am J Cardiol
1 Am J Med
3 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
2 Chest
1 Circ Genom Precis Med
4 Circulation
6 Clin Cardiol
23 Eur Heart J
112 Int J Cardiol
4 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
2 J Mol Cell Cardiol
3 J Thorac Cardiovasc Surg
2 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. KRITTANAWONG C, Yue B, Mahtta D, Kumar A, et al
    Hospital Readmission in Patients With Spontaneous Coronary Artery Dissection.
    Am J Cardiol. 2021 May 21. pii: S0002-9149(21)00321.
    PubMed         Abstract available

  2. CHEZAR-AZERRAD C, Musallam A, Shea C, Zhang C, et al
    One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery.
    Am J Cardiol. 2021 May 21. pii: S0002-9149(21)00315.
    PubMed         Abstract available

    Am J Med

  3. PAGIDIPATI NJ, Deedwania DP
    A comprehensive cardiovascular-renal-metabolic risk reduction approach to patients with Type 2 Diabetes Mellitus.
    Am J Med. 2021 May 21. pii: S0002-9343(21)00317.
    PubMed         Abstract available

    Ann Thorac Surg

  4. ABDULKARIM M, Weld J, Cohen W, Combs P, et al
    Congenitally Abnormal Aortic Valve causing Coronary Obstruction and Cardiac Arrest in Infancy.
    Ann Thorac Surg. 2020 Oct 15. pii: S0003-4975(20)31686.
    PubMed         Abstract available

  5. ANDERSON M, Smith D, Kane P, Lee R, et al
    Impella 5.5 Direct Aortic Implant and Explant Techniques.
    Ann Thorac Surg. 2021;111:e373-e375.
    PubMed         Abstract available

  6. TEMAN NR, Hawkins RB, Charles EJ, Mehaffey JH, et al
    Minimally Invasive vs Open Coronary Surgery: A Multi-Institutional Analysis of Cost and Outcomes.
    Ann Thorac Surg. 2021;111:1478-1484.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  7. Correction to: Naive CD8(+) T Cells Expressing CD95 Increase Human Cardiovascular Disease Severity.
    Arterioscler Thromb Vasc Biol. 2021;41:e383.

  8. CHATZOPOULOU E, Range H, Deraz O, Boutouyrie P, et al
    Poor Masticatory Capacity and Blood Biomarkers of Elevated Cardiovascular Disease Risk in the Community: The Paris Prospective Study III.
    Arterioscler Thromb Vasc Biol. 2021 May 27:ATVBAHA121316085.
    PubMed         Abstract available


  9. WEI Y, Lv J, Guo Y, Bian Z, et al
    Age-specific associations between habitual snoring and cardiovascular diseases in China: a 10-year cohort study.
    Chest. 2021 May 21. pii: S0012-3692(21)00905-3. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  10. TAN LD
    Further Insight Into the Intimate Relationship Between Asthma and Cardiovascular Disease.
    Chest. 2021;159:1311-1312.

    Circ Genom Precis Med

  11. CHRISTIANSEN MK, Winther S, Nissen L, Vilhjalmsson BJ, et al
    Polygenic Risk Score-enhanced Risk Stratification of Coronary Artery Disease in Patients with Stable Chest Pain.
    Circ Genom Precis Med. 2021 May 25. doi: 10.1161/CIRCGEN.120.003298.
    PubMed         Abstract available


  12. ALTHOUSE AD, Below JE, Claggett BL, Cox NJ, et al
    Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.
    Circulation. 2021 May 25:CIRCULATIONAHA121055393.
    PubMed         Abstract available

  13. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.

  14. CHANG AY, Barry M, Harrington RA
    The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire.
    Circulation. 2021;143:2029-2031.

  15. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.

    Clin Cardiol

  16. KAIHARA T, Higuma T, Izumo M, Kotoku N, et al
    Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23655.
    PubMed         Abstract available

  17. LAM ASM, Yan BPY, Lee VWY
    Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post-acute coronary syndrome patients-A 10-year cohort study.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23653.
    PubMed         Abstract available

  18. WANG SJ, Zhao HY, Fan XT
    Reply to the Letter to the Editor Entitled "Optimal risk stratification and therapeutic strategy for acute myocardial infarction".
    Clin Cardiol. 2021 May 22. doi: 10.1002/clc.23646.

  19. EGGERS KM, Baron T, Hjort M, Nordenskjold AM, et al
    Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23651.
    PubMed         Abstract available

  20. MENG Z, Yang J, Wu J, Zheng X, et al
    Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23648.
    PubMed         Abstract available

  21. TOMER O, Leibowitz D, Einhorn-Cohen M, Shlomo N, et al
    The impact of short hospital stay on prognosis after acute myocardial infarction: An analysis from the ACSIS database.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23652.
    PubMed         Abstract available

    Eur Heart J

  22. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed         Abstract available

  23. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    PubMed         Abstract available

  24. IBANEZ B, Roque D, Price S
    The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care.
    Eur Heart J. 2021;42:884-895.

  25. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    PubMed         Abstract available

  26. RAY KK
    Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.
    Eur Heart J. 2021;42:253-256.

  27. ZHANG H, Xiao Z, Yang P, Hu J, et al
    Ruptured coronary artery aneurysm mimicking as a giant mediastinal mass.
    Eur Heart J. 2021;42:1183.

  28. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    PubMed         Abstract available

  29. SICARI R
    The curious incident of CFVR in clinical practice.
    Eur Heart J. 2021;42:240-242.

  30. WANG X, Yan C
    Progression of artery aneurysm after transcatheter closure of coronary artery fistula.
    Eur Heart J. 2021;42:918.

  31. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    PubMed         Abstract available

  32. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.

  33. JOBS A, Collet JP, Thiele H
    Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?
    Eur Heart J. 2021;42:353-354.

  34. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.

  35. PLAT J, Strandberg TE, Gylling H
    Intestinal cholesterol and phytosterol absorption and the risk of coronary artery disease.
    Eur Heart J. 2021;42:281-282.

  36. HELGADOTTIR A, Thorleifsson G, Stefansson K
    Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers.
    Eur Heart J. 2021;42:283-284.

  37. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
    Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
    Eur Heart J. 2021;42:287.

  38. ERDMANN J, van der Laan SW
    Unfolding and disentangling coronary vascular disease through genome-wide association studies.
    Eur Heart J. 2021;42:934-937.

  39. MARENZI G, Cosentino N, Cardinale D
    Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
    Eur Heart J. 2021;42:1035-1037.

  40. Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials.
    Eur Heart J. 2021 May 23. pii: 6282430. doi: 10.1093.

  41. SCHRODER J, Michelsen MM, Mygind ND, Suhrs HE, et al
    Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Eur Heart J. 2021;42:228-239.
    PubMed         Abstract available

  42. VARBO A, Nordestgaard BG
    Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
    Eur Heart J. 2021 May 23. pii: 6282433. doi: 10.1093.
    PubMed         Abstract available

  43. VAN DER STOUWE JG, Boeddinghaus J, Mueller C
    Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    Eur Heart J. 2021 May 23. pii: 6282428. doi: 10.1093.

  44. HOLT A, Blanche P, McGettigan P, Lamberts M, et al
    Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis.
    Eur Heart J. 2021 May 23. pii: 6282429. doi: 10.1093.

    Int J Cardiol

  45. LEONE AM, Arioti M, Cialdella P, Vergallo R, et al
    Prognostic impact of FFR/contrast FFR discordance.
    Int J Cardiol. 2021;327:40-44.
    PubMed         Abstract available

  46. LAWLESS M, Harrison AS, Doherty P
    Multiple interventions following an acute coronary syndrome event increase uptake into cardiac rehabilitation.
    Int J Cardiol. 2021;326:1-5.
    PubMed         Abstract available

  47. ZHAI Y, Yang J, Zhang J, Yang J, et al
    miRNA-3614 derived from epicardial adipose tissue: A novel target for ischemic heart diseases.
    Int J Cardiol. 2021;326:157.

  48. GRESELE P, Guglielmini G, Del Pinto M, Calabro P, et al
    Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
    Int J Cardiol. 2021;327:176-182.
    PubMed         Abstract available

  49. SHIMA Y, Miura K, Shimada T, Ohya M, et al
    Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Int J Cardiol. 2021;326:12-18.
    PubMed         Abstract available

  50. CAI Q, Gao ML, Huang LS, Pan LH, et al
    lncRNA H19/miRNA-1: Another potential mechanism for treating myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;322:57.

  51. BRUNO VD, Zakkar M
    Instantaneous wave- free ratio for decision making in cardiac surgery, an important step in the right direction.
    Int J Cardiol. 2021;326:71-72.

    Acute coronary occlusion in non-STEMI: If you change the way you look at things, the things you look at change.
    Int J Cardiol. 2021;322:49-50.

  53. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    PubMed         Abstract available

  54. LIU H, Xie G, Huang W, Liu J, et al
    Rationale and design of a multicenter, randomized, patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease (ENDOFIND).
    Int J Cardiol. 2021;325:16-22.
    PubMed         Abstract available

  55. LAUKKANEN JA, Kunutsor SK
    Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
    Int J Cardiol. 2021;324:13-21.
    PubMed         Abstract available

  56. WU X, Ma JN, Shen LJ, Hu SY, et al
    Reply to "The differential diagnosis of STEMI should also be taken into account".
    Int J Cardiol. 2021;322:55.

  57. OZGEYIK M, Okay Ozgeyik M, Yildirim OT
    Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population.
    Int J Cardiol. 2021;322:56.

  58. SONG X
    The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation.
    Int J Cardiol. 2021;323:22.

  59. ZHOU J, Chin CT, Huang X, Guo N, et al
    Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
    Int J Cardiol. 2021;327:19-24.
    PubMed         Abstract available

  60. TAMARAPPOO B, Samuel TJ, Elboudwarej O, Thomson LEJ, et al
    Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Int J Cardiol. 2021;327:25-30.
    PubMed         Abstract available

  61. JEFFRIES A, Costello B, Corkill W, Varghese S, et al
    Prognostic value of coronary artery calcium scoring and computed tomography coronary angiography in remote Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2021;328:241-246.
    PubMed         Abstract available

  62. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    PubMed         Abstract available

  63. LEDDA RE, Milanese G, Sverzellati N
    Might EAT composition help to predict coronary artery disease severity?
    Int J Cardiol. 2021;327:39.

  64. MONTALTO C, Crimi G, Morici N, Piatti L, et al
    Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
    Int J Cardiol. 2021;328:22-28.
    PubMed         Abstract available

  65. EARLE NJ, Poppe KK, Rolleston A, Devlin G, et al
    Outcomes for working age patients after first-time acute coronary syndrome - ANZACS-QI 35.
    Int J Cardiol. 2021;328:55-58.
    PubMed         Abstract available

  66. NICOLAS J, Claessen BE, Cao D, Chiarito M, et al
    A sex paradox in clinical outcomes following complex percutaneous coronary intervention.
    Int J Cardiol. 2021;329:67-73.
    PubMed         Abstract available

  67. PAPP S, Barczi G, Karady J, Kolossvary M, et al
    Coronary plaque burden of the left anterior descending artery in patients with or without myocardial bridge: A case-control study based on coronary CT-angiography.
    Int J Cardiol. 2021;327:231-235.
    PubMed         Abstract available

  68. PAVASINI R, Cardelli LS, Piredda A, Tonet E, et al
    Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes.
    Int J Cardiol. 2021;327:31-35.
    PubMed         Abstract available

  69. YING S, Li X
    Renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;327:36.

  70. HUANG W, Wu X, Xue Y, Zhou Y, et al
    Reply to the Letter to the Editor: "The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation".
    Int J Cardiol. 2021;327:37.

  71. JINNOUCHI H, Sato Y, Cheng Q, Janifer C, et al
    Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
    Int J Cardiol. 2021;327:52-57.
    PubMed         Abstract available

  72. TAVENIER AH, Hermanides RS, Fabris E, Angiolillo DJ, et al
    Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI.
    Int J Cardiol. 2021;328:40-45.
    PubMed         Abstract available

  73. LI L, Guan C, Meng S, Bai Y, et al
    Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.
    Int J Cardiol. 2021;327:45-51.
    PubMed         Abstract available

  74. RIEHLE L, Frohlich GM
    Reply to "Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population".
    Int J Cardiol. 2021;327:38.

  75. CASE BC, Yerasi C, Forrestal BJ, Shlofmitz E, et al
    Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease.
    Int J Cardiol. 2021;325:168-175.
    PubMed         Abstract available

  76. SABBAH M, Engstrom T, Nepper-Christensen L, Lonborg J, et al
    Does infarct localization and collateral supply confound the association between antiplatelet treatment and infarct size in STEMI?
    Int J Cardiol. 2021;326:42.

  77. KEECH A, Way K, Holgate K, Fildes J, et al
    HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor.
    Int J Cardiol. 2021;322:291-292.

  78. POLYAKOVA EA, Zaraiskii MI, Mikhaylov EN, Baranova EI, et al
    Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study.
    Int J Cardiol. 2021;322:9-15.
    PubMed         Abstract available

  79. MANGIACAPRA F, Bressi E, Viscusi MM, Creta A, et al
    Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study.
    Int J Cardiol. 2021;322:16-22.
    PubMed         Abstract available

    Electrocardiogram features and course in patients with takotsubo syndrome.
    Int J Cardiol. 2021;324:22.

  81. DAI Y, Huang J, Chen Y, Chang S, et al
    Circulating CD34+VEGFR-2+ endothelial progenitor cells correlate with revascularization-mediated long-term improvement of cardiac function in patients with coronary chronic total occlusions.
    Int J Cardiol. 2021;322:1-8.
    PubMed         Abstract available

  82. PENG Y, Du X, Li X, Ji J, et al
    Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.
    Int J Cardiol. 2021;323:7-12.
    PubMed         Abstract available

  83. WU L, Yu J, Wang Q, Lu Y, et al
    Effects of nalbuphine on the cardioprotective effect of morphine in rats.
    Int J Cardiol. 2021;322:207-210.
    PubMed         Abstract available

  84. KATAJA A, Tarvasmaki T, Lassus J, Sionis A, et al
    Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study.
    Int J Cardiol. 2021;322:191-196.
    PubMed         Abstract available

  85. KATAOKA Y, Doi T
    Coronary artery ectasia: Importance of its risk stratification and management.
    Int J Cardiol. 2021;322:43-44.

  86. LUSINI M, Nenna A, Chello M
    Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
    Int J Cardiol. 2021;322:211-212.

  87. PASTORI D, Carnevale R, Stanzione R, Nocella C, et al
    T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
    Int J Cardiol. 2020 Aug 27. pii: S0167-5273(20)33704.
    PubMed         Abstract available

  88. GUI D, Huang W
    Coronary artery disease is accompanied by increased epicardial fat volume.
    Int J Cardiol. 2021;323:21.

  89. LAKSHMANAN S, Budoff MJ
    Where ISCHEMIA fails, coronary CTA shines.
    Int J Cardiol. 2021;322:40-42.

  90. CHOI KH, Lee SH, Lee JM, Hwang D, et al
    Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease.
    Int J Cardiol. 2021;325:23-29.
    PubMed         Abstract available

    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.

    The differential diagnosis of STEMI should also be taken into account.
    Int J Cardiol. 2021;323:19.

  93. SARAIVA FA, Cerqueira RJ, Savarese G, Leite-Moreira AF, et al
    The tight tie of MAG versus SAG in CABG.
    Int J Cardiol. 2021;323:26.

  94. FRACASSI F, Niccoli G, Cosentino N, Eligini S, et al
    Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation.
    Int J Cardiol. 2021;325:1-8.
    PubMed         Abstract available

    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.

  96. KATAOKA T, Harada K, Tanaka A, Onishi T, et al
    Relationship between epicardial adipose tissue volume and coronary artery spasm.
    Int J Cardiol. 2021;324:8-12.
    PubMed         Abstract available

  97. LI D, Xiong G, Zeng H, Zhou Q, et al
    Machine learning-aided risk stratification system for the prediction of coronary artery disease.
    Int J Cardiol. 2021;326:30-34.
    PubMed         Abstract available

  98. SURUGA K, Miyoshi T, Kotani K, Ichikawa K, et al
    Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.
    Int J Cardiol. 2021;324:193-198.
    PubMed         Abstract available

  99. VENETSANOS D, Omerovic E, Sarno G, Pagonis C, et al
    Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
    Int J Cardiol. 2021;325:30-36.
    PubMed         Abstract available

  100. IANNACCONE M, Albani S, Giannini F, Colangelo S, et al
    Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
    Int J Cardiol. 2021;324:44-51.
    PubMed         Abstract available

  101. WADA T, Shiono Y, Kubo T, Honda K, et al
    Impact of instantaneous wave-free ratio on graft failure after coronary artery bypass graft surgery.
    Int J Cardiol. 2021;324:23-29.
    PubMed         Abstract available

  102. HUANG W, Wu X, Xue Y, Zhou Y, et al
    MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-kappaB signaling in the epicardial adipose tissue with coronary artery disease.
    Int J Cardiol. 2021;324:152-164.
    PubMed         Abstract available

  103. SELVANAYAGAM JB, Ananthakrishna R, Shirodaria C, Channon K, et al
    Timing of cardiovascular magnetic resonance in clinical trials evaluating cardioprotective therapies to reduce infarct size.
    Int J Cardiol. 2021;323:272-274.

  104. ALMENDRO-DELIA M, Seoane Garcia T, Villar Calle P, Garcia Gonzalez N, et al
    Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes.
    Int J Cardiol. 2021;324:1-7.
    PubMed         Abstract available

  105. IBRAHIM IM, Farag EM, Tabl MAE, Abdelaziz M, et al
    Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease.
    Int J Cardiol. 2021;322:29-33.
    PubMed         Abstract available

  106. YAMADA H
    Epicardial adipose tissue volume is not a simple marker of coronary artery disease.
    Int J Cardiol. 2021;322:45.

  107. SUGISAWA J, Matsumoto Y, Takeuchi M, Suda A, et al
    Beneficial effects of exercise training on physical performance in patients with vasospastic angina.
    Int J Cardiol. 2021;328:14-21.
    PubMed         Abstract available

  108. VERWEIJ L, Jorstad HT, Minneboo M, Ter Riet G, et al
    The influence of partners on successful lifestyle modification in patients with coronary artery disease.
    Int J Cardiol. 2021;332:195-201.
    PubMed         Abstract available

  109. SUPPOGU N, Wei J, Quesada O, Shufelt C, et al
    Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
    Int J Cardiol. 2021;333:35-39.
    PubMed         Abstract available

  110. STEINER J, Kerschl M, Erbay A, Abdelwahed YS, et al
    Impact of renal function on outcomes of patients with cardiac troponin elevation and non-obstructive coronary arteries.
    Int J Cardiol. 2021;333:29-34.
    PubMed         Abstract available

  111. SANTOS-PARDO I, Lagerqvist B, Ritsinger V, Witt N, et al
    Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.
    Int J Cardiol. 2021;330:23-29.
    PubMed         Abstract available

  112. SENGUTTUVAN NB, Suman F, Paneerselvam T, Malepati B, et al
    Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial.
    Int J Cardiol. 2021;330:1-6.
    PubMed         Abstract available

  113. ASLANGER EK, Meyers HP, Bracey A, Smith SW, et al
    The STEMI/NonSTEMI Dichotomy needs to be replaced by Occlusion MI vs. Non-Occlusion MI.
    Int J Cardiol. 2021;330:15.

  114. DEMIR OM, Schrieken C, Curio J, Rahman H, et al
    Behavioural determinants impacting the adoption rate of coronary physiology.
    Int J Cardiol. 2021;330:12-14.
    PubMed         Abstract available

  115. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    PubMed         Abstract available

  116. SCHERRENBERG M, Janssen J, Lauwers A, Schreurs I, et al
    Is there an optimal dose of cardiac rehabilitation in coronary artery disease patients?
    Int J Cardiol. 2021;330:7-11.
    PubMed         Abstract available

  117. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    PubMed         Abstract available

  118. FUNAYAMA N, Kayanuma K, Sunaga D, Yamamoto T, et al
    Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
    Int J Cardiol. 2021;330:35-40.
    PubMed         Abstract available

  119. DI SERAFINO L, Mangiacapra F, Pyxaras S, Morisco C, et al
    Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography.
    Int J Cardiol. 2021;333:8-13.
    PubMed         Abstract available

  120. ALMENDRO-DELIA M, Izquierdo-Bajo A, Madrona-Jimenez L, Blanco-Ponce E, et al
    Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry.
    Int J Cardiol. 2021;332:29-34.
    PubMed         Abstract available

  121. AKSIT E, Altay S, Altun A
    The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment.
    Int J Cardiol. 2021;332:38.

  122. SCIAGRA R, Di Paolantonio M, Rubino F, Arnone A, et al
    The STREAM trial: Great expectations for getting clearness in an opaque disease.
    Int J Cardiol. 2021;332:140-141.

  123. CHAO CJ, Shanbhag A, Chiang CC, Girardo ME, et al
    Baseline thrombocytopenia in acute coronary syndrome: The lower, the worse.
    Int J Cardiol. 2021;332:1-7.
    PubMed         Abstract available

  124. XIE Z, Zhu J, Li W, Liu L, et al
    Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease.
    Int J Cardiol. 2021;332:8-14.
    PubMed         Abstract available

  125. COMELLA A, Michail M, Chan J, Cameron JD, et al
    Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
    PubMed         Abstract available

  126. SHYU KG, Wang BW, Lin CM
    Reply to the letter to the Editor "ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2021;332:39.

  127. TIAN B, Li T, Wang M
    MicroRNA-19a might be a new potential therapeutic target in the treatment of coronary artery disease.
    Int J Cardiol. 2021;332:164.

  128. KONST RE, Damman P, Pellegrini D, Hartzema-Meijer MJ, et al
    Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Int J Cardiol. 2021;333:14-20.
    PubMed         Abstract available

  129. POLZIN A, Helten C, Dannenberg L, Muller T, et al
    Sphingosine-1-phosphate: A mediator of the ARB-MI paradox?
    Int J Cardiol. 2021;333:40-42.
    PubMed         Abstract available

  130. TESCHE C, Ellis L, Brandt V
    Non-invasive plaque morphology-based FFR assessment: A new approach to predict ischemic coronary artery disease?
    Int J Cardiol. 2021;332:223-224.

  131. ALMUKDAD S, Elewa H, Arafa S, Al-Badriyeh D, et al
    Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar.
    Int J Cardiol. 2021;331:27-34.
    PubMed         Abstract available

  132. SEITZ A, Ong P
    Coexisting microvascular dysfunction in patients with diffuse epicardial coronary spasm: A novel piece of the coronary vasomotor disorder puzzle.
    Int J Cardiol. 2021;331:12-13.

  133. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed         Abstract available

  134. SAMBOLA A, Soriano-Colome T
    A sex paradox in clinical outcomes following complex percutaneous intervention. Treatment bias, biology or both?
    Int J Cardiol. 2021;329:77-78.

  135. MOHAMED MO, Rashid M, Timmis A, Clarke S, et al
    Sex differences in distribution, management and outcomes of combined ischemic-bleeding risk following acute coronary syndrome.
    Int J Cardiol. 2021;329:16-22.
    PubMed         Abstract available

  136. MARTINSSON A, Nielsen SJ, Bjorklund E, Pivodic A, et al
    Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry.
    Int J Cardiol. 2021;331:40-45.
    PubMed         Abstract available

  137. LEE J, Park DW
    Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question.
    Int J Cardiol. 2021;329:46-47.

  138. CAI Q, Gao ML, Huang LS, Chen HS, et al
    MALAT1/miRNA-203/Wnt5a: A potential mechanism for regulating coronary artery disease.
    Int J Cardiol. 2021;329:48.

  139. HUANG S, Zeng Z, Sun Y, Cai Y, et al
    Association study of hsa_circ_0001946, hsa-miR-7-5p and PARP1 in coronary atherosclerotic heart disease.
    Int J Cardiol. 2021;328:1-7.
    PubMed         Abstract available

  140. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    PubMed         Abstract available

  141. YOUSIF N, Niederseer D, Davies A, El Issa M, et al
    Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
    Int J Cardiol. 2021;328:8-13.
    PubMed         Abstract available

  142. AHMAD A, Corban MT, Lerman A
    Contrast fractional flow reserve vs adenosine fractional flow reserve: The impact of discordant results.
    Int J Cardiol. 2021;328:59-60.

  143. ORBAN M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, et al
    Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
    Int J Cardiol. 2021;328:227-234.
    PubMed         Abstract available

  144. PENG Y
    Reply to renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;329:49.

  145. DEKKER M, Waissi F, Bank IEM, Isgum I, et al
    The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from (82)Rb-PET/CT myocardial perfusion imaging.
    Int J Cardiol. 2021;329:9-15.
    PubMed         Abstract available

  146. HOCHHOLZER W, Valina CM
    Antiplatelet therapy for STEMI: Hit it hard and early?
    Int J Cardiol. 2021;328:61-62.

  147. SCHULZ S, Reichert S, Grollmitz J, Friebe L, et al
    The role of Saccharibacteria (TM7) in the subginival microbiome as a predictor for secondary cardiovascular events.
    Int J Cardiol. 2021;331:255-261.
    PubMed         Abstract available

  148. FABRIS E, Bhatt DL
    Variation in treatment strategy for NSTEMI: A complex phenomenon.
    Int J Cardiol. 2021;331:14-16.

  149. VARGA-SZEMES A, Schoepf UJ, Maurovich-Horvat P, Wang R, et al
    Coronary plaque assessment of Vasodilative capacity by CT angiography effectively estimates fractional flow reserve.
    Int J Cardiol. 2021;331:307-315.
    PubMed         Abstract available

  150. HAITJEMA S, Hoefer IE
    Towards affordable diagnostics and risk management in cardiology: As simple as counting cells?
    Int J Cardiol. 2021;331:206-207.

    Anti-thrombotic therapy for medically managed patients after non-ST segment elevation acute coronary syndromes: Balancing the scales of ischaemic and bleeding risk.
    Int J Cardiol. 2021;331:10-11.

  152. VERDOIA M, De Luca G
    Comments on "Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome".
    Int J Cardiol. 2021;331:8-9.

  153. XIE H, Mao Y, Wang M
    Tackling PTEN induced putative kinase 1 in angiotensin II-induced myocardial injury.
    Int J Cardiol. 2021;331:211.

  154. REINDL M, Reinstadler SJ
    E-wave propagation index (EPI) - A promising echocardiographic marker to improve left ventricular thrombus detection after STEMI?
    Int J Cardiol. 2021;331:331-332.

  155. BETTINK S, Lochel M, Peters D, Haider W, et al
    Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model.
    Int J Cardiol. 2021;331:46-56.
    PubMed         Abstract available

  156. PARCO C, Brockmeyer M, Kosejian L, Quade J, et al
    Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort.
    Int J Cardiol. 2021;329:28-35.
    PubMed         Abstract available

    J Am Coll Cardiol

  157. HUFFMAN MD, Kwan GF
    RESPONSE: Multilateral Cardiovascular Education and Training in Haiti.
    J Am Coll Cardiol. 2021;77:2752-2753.

  158. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    PubMed         Abstract available

  159. HAYNES N, Saint-Joy V, Swain J
    Global Health Imperative to Prioritizing Cardiovascular Education.
    J Am Coll Cardiol. 2021;77:2749-2753.

  160. HENRY TD, Garcia S
    Resilience in the Face of Adversity: The Cardiology Community Comes Together.
    J Am Coll Cardiol. 2021;77:2477-2479.

    J Cardiovasc Pharmacol

  161. YUAN JL, Yin CY, Li YZ, Song S, et al
    EZH2 as an epigenetic regulator of cardiovascular development and diseases.
    J Cardiovasc Pharmacol. 2021 May 19. pii: 00005344-900000000-98225.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  162. HOU W, Gao J, Jiang W, Wei W, et al
    Meal Timing of Subtypes of Macronutrients Consumption With Cardiovascular Diseases: NHANES, 2003 to 2016.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6279652. doi: 10.1210.
    PubMed         Abstract available

    J Mol Cell Cardiol

  163. KOVALIK JP, Zhao X, Gao F, Leng S, et al
    Amino acid differences between diabetic older adults and non-diabetic older adults and their associations with cardiovascular function.
    J Mol Cell Cardiol. 2021 May 22. pii: S0022-2828(21)00103.
    PubMed         Abstract available

  164. MOUTON AJ, Flynn ER, Moak SP, Aitken NM, et al
    Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.
    J Mol Cell Cardiol. 2021;158:38-48.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  165. TAGGART DP, Gavrilov Y, Krasopoulos G, Rajakaruna C, et al
    External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial.
    J Thorac Cardiovasc Surg. 2021 Apr 21. pii: S0022-5223(21)00723.
    PubMed         Abstract available

  166. LANUTI M, Lin J, Ng T, Burt BM, et al
    A year in general thoracic surgery published in the Journal of Thoracic and Cardiovascular Surgery: 2020.
    J Thorac Cardiovasc Surg. 2021 Apr 20. pii: S0022-5223(21)00665.

  167. GAUDINO M, Di Franco A, Spadaccio C, Rahouma M, et al
    Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis.
    J Thorac Cardiovasc Surg. 2021 Apr 29. pii: S0022-5223(21)00746.
    PubMed         Abstract available

    N Engl J Med

  168. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.

  169. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.